A new formulation of 0.1% hydrocortisone cream with vasoconstrictor activity and clinical effectiveness.
A new formulation of hydrocortisone with vasoconstrictor activity has been shown to be effective clinically and was more effective in a 0.1% concentration than 1.0% Hydrocortisone Cream BPC. Its use should obviate the adverse effects of fluorinated steroids.
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D007464:Clioquinol / Q000008:administration & dosage / Q000627:therapeutic use; D004338:Drug Combinations; D004485:Eczema / Q000188:drug therapy; D006801:Humans; D006854:Hydrocortisone; D010919:Placebos; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D004338:Drug Combinations; D010919:Placebos; D014662:Vasoconstrictor Agents; D007464:Clioquinol; D006854:Hydrocortisone